📰 Genentech News
Page 200 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 21, 2023
/PRNewswire/ -- Vivtex Corporation, a pre-clinical drug development company with a high throughput GI screening technology, that converts drugs requiring...
February 20, 2023
Menlo Park, California (PRWEB) February 20, 2023 -- America’s healthcare system continues to suffer from disparities in care and outcomes – with minority
February 20, 2023
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of e
February 19, 2023
Stanford University president Marc Tessier-Lavigne was formerly executive vice president for research and chief scientific officer at biotech giant Genentech, according to his page on Wikipedia. "In 2022, Stanford University opened an investigation into allegations of Tessier-Lavignes involvement...
February 19, 2023
SAN FRANCISCO — Adjuvant nivolumab improved outcomes compared with placebo for patients with high-risk muscle-invasive urothelial carcinoma, according to study results.Extended follow-up of the randomized phase 3 CheckMate 274 trial — presented at ASCO Genitourinary Cancers Symposium — showed the agent extended DFS, non–urothelial tract recurrence-free survival and distant
February 18, 2023
Marc Tessier-Lavigne sent faculty and staff an email Friday stating that The Daily's reporting on allegations that his Alzheimer's research contained falsified data was "replete with falsehoods." Daily Editor in Chief Sam Catania ’24 said the paper stands by its reporting.
February 17, 2023
Operator: Good day and thank you for standing by and welcome to the Fourth Quarter and Full Year 2022 Conference Call. . Please be advised that todays conference is being recorded.
February 17, 2023
Brandee Evans, best known for her role as “Mercedes” in Starz' hit series "P-Valley", is getting candid about her real-life role as her mother's caregiver.
February 17, 2023
/PRNewswire/ -- Group consolidated accounts have been prepared for the fourth quarter, and full year, which includes the consolidation of NeoDynamics AB,...
February 17, 2023
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.